We’re excited to join BioJapan 2026 in Yokohama, Japan, October 7โ9, and connect with partners from across the global biotech community.
We’ll be showcasing our medical countermeasure autoinjectors for CBRN threats, including products already U.S.-FDA-approved and supplied to allied governments and military organizations worldwide. Built for emergency response and austere conditions, where speed and reliable drug delivery are critical.
Our pipeline also includes trauma care products for acute pain and major bleeding, reflecting our commitment to field-ready solutions across acute medical indications.
With today’s shifting geopolitical landscape and emerging threats like drones, medical preparedness has never been more important.
๐ฉ Want to learn more or set up a meeting in Yokohama? Reach out: biodefense@rafa.co.il
